Insulin and IGF1 signalling pathways in human astrocytes in vitro and in vivo; characterisation, subcellular localisation and modulation of the receptors

Molecular Brain

Volumn 8, Issue 1, 2015, Pages

  Garwood, Claire J ^a   Ratcliffe, Laura E ^a   Morgan, Sarah V ^a   Simpson, Julie E ^a   Owens, Helen ^a   Vazquez Villaseñor, Irina ^a   Heath, Paul R ^a   Romero, Ignacio A ^b   Ince, Paul G ^a   Wharton, Stephen B ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b OPEN UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; FRUCTOSE; INSULIN RECEPTOR; ISOPROTEIN;

ADULT; AGED; AGING; ALZHEIMER DISEASE; ARTICLE; ASTROCYTE; CASE REPORT; CELL CULTURE; CELL FRACTIONATION; CELL GROWTH; CELL MODULATION; CELL VIABILITY; CELLULAR DISTRIBUTION; CELLULAR PARAMETERS; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN VITRO STUDY; IN VIVO STUDY; MALE; MIDDLE AGED; MTT ASSAY; NEUROPATHOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; BRAIN; CELL PROLIFERATION; CELL SURVIVAL; DRUG EFFECTS; METABOLISM; PHOSPHORYLATION; PROTEIN TRANSPORT;

AGED; ASTROCYTES; BRAIN; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; FEMALE; FRUCTOSE; HUMANS; IMMUNOHISTOCHEMISTRY; INSULIN; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; PHOSPHORYLATION; PROTEIN ISOFORMS; PROTEIN TRANSPORT; RECEPTOR, IGF TYPE 1; RECEPTOR, INSULIN; SIGNAL TRANSDUCTION; SUBCELLULAR FRACTIONS;

EID: 84939812553     PISSN: None     EISSN: 17566606     Source Type: Journal    
DOI: 10.1186/s13041-015-0138-6     Document Type: Article

References (59)

1. O'Neill C, Kiely AP, Coakley MF, Manning S, Long-Smith CM. Insulin and IGF-1 signalling: longevity, protein homoeostasis and Alzheimer's disease. Biochem Soc Trans. 2012;40(4):721-7. PubMed PMID: 22817723. Epub 2012/07/24. eng.
2. Griffin RJ, Moloney A, Kelliher M, Johnston JA, Ravid R, Dockery P, et al. Activation of Akt/PKB, increased phosphorylation of Akt substrates and loss and altered distribution of Akt and PTEN are features of Alzheimer's disease pathology. J Neurochem. 2005;93(1):105-17. PubMed PMID: 15773910. Epub 2005/03/19. eng.
3. Kim EK, Choi EJ. Pathological roles of MAPK signaling pathways in human diseases. Biochim Biophys Acta. 2010;1802(4):396-405. PubMed PMID: 20079433. Epub 2010/01/19. eng.
4. Hers I, Vincent EE, Tavare JM. Akt signalling in health and disease. Cell Signal. 2011;23(10):1515-27. PubMed PMID: 21620960. Epub 2011/05/31. eng.
5. Moloney AM, Griffin RJ, Timmons S, O'Connor R, Ravid R, O'Neill C. Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling. Neurobiol Aging. 2010;31(2):224-43. PubMed PMID: 18479783. Epub 2008/05/16. eng.
6. Steen E, Terry BM, Rivera EJ, Cannon JL, Neely TR, Tavares R, et al. Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease - is this type 3 diabetes? J Alzheimers Dis. 2005;7(1):63-80. PubMed PMID: 15750215. Epub 2005/03/08. eng.
7. Peila R, Rodriguez BL, Launer LJ. Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study. Diabetes. 2002;51(4):1256-62. PubMed PMID: 11916953. Epub 2002/03/28. eng.
8. Biessels GJ, Staekenborg S, Brunner E, Brayne C, Scheltens P. Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol. 2006;5(1):64-74. PubMed PMID: 16361024. Epub 2005/12/20. eng.
9. Vagelatos NT, Eslick GD. Type 2 Diabetes as a Risk Factor for Alzheimer's Disease: The Confounders, Interactions, and Neuropathology Associated With This Relationship. Epidemiol Rev. 2013;35:152-60. PubMed PMID: 23314404. Epub 2013/01/15. Eng.
10. Nedergaard M, Ransom B, Goldman SA. New roles for astrocytes: redefining the functional architecture of the brain. Trends Neurosci. 2003;26(10):523-30. PubMed PMID: 14522144. Epub 2003/10/03. eng.
11. Parpura V, Heneka MT, Montana V, Oliet SH, Schousboe A, Haydon PG, et al. Glial cells in (patho)physiology. J Neurochem. 2012;121(1):4-27. PubMed PMID: 22251135. Pubmed Central PMCID: PMC3304021. Epub 2012/01/19. eng.
12. Garcia-Marin V, Garcia-Lopez P, Freire M. Cajal's contributions to the study of Alzheimer's disease. J Alzheimers Dis. 2007;12(2):161-74. PubMed PMID: 17917161. Epub 2007/10/06. eng.
13. Steele ML, Robinson SR. Reactive astrocytes give neurons less support: implications for Alzheimer's disease. Neurobiol Aging. 2010;33(2):423.e1-13. PubMed PMID: 21051108. Epub 2010/11/06. Eng.
14. Sofroniew MV, Vinters HV. Astrocytes: biology and pathology. Acta Neuropathol. 2010;119(1):7-35. PubMed PMID: 20012068. Pubmed Central PMCID: 2799634. Epub 2009/12/17. eng.
15. Pekny M, Nilsson M. Astrocyte activation and reactive gliosis. Glia. 2005;50(4):427-34. PubMed PMID: 15846805. Epub 2005/04/23. eng.
16. Rodriguez JJ, Olabarria M, Chvatal A, Verkhratsky A. Astroglia in dementia and Alzheimer's disease. Cell Death Differ. 2009;16(3):378-85. PubMed PMID: 19057621. Epub 2008/12/06. eng.
17. Olabarria M, Noristani HN, Verkhratsky A, Rodriguez JJ. Concomitant astroglial atrophy and astrogliosis in a triple transgenic animal model of Alzheimer's disease. Glia. 2010;58(7):831-8. PubMed PMID: 20140958. Epub 2010/02/09. eng.
18. Simpson JE, Ince PG, Lace G, Forster G, Shaw PJ, Matthews F, et al. Astrocyte phenotype in relation to Alzheimer-type pathology in the ageing brain. Neurobiol Aging. 2010;31(4):578-90. PubMed PMID: 18586353. Epub 2008/07/01. eng.
19. Wharton SB, Brayne C, Savva GM, Matthews FE, Forster G, Simpson J, et al. Epidemiological neuropathology: the MRC Cognitive Function and Aging Study experience. J Alzheimers Dis. 2011;25(2):359-72. PubMed PMID: 21422529. Epub 2011/03/23. eng.
20. Garwood C, Faizullabhoy A, Wharton SB, Ince PG, Heath P, Shaw PJ, et al. Calcium dysregulation in relation to Alzheimer-type pathology in the ageing brain. Neuropathol Appl Neurobiol. 2013;39(7):788-99. PubMed PMID: 23421725. Epub 2013/02/21. Eng.
21. Simpson JE, Ince PG, Shaw PJ, Heath PR, Raman R, Garwood CJ, et al. Microarray analysis of the astrocyte transcriptome in the aging brain: relationship to Alzheimer's pathology and APOE genotype. Neurobiol Aging. 2011;32(10):1795-807. PubMed PMID: 21705112. Epub 2011/06/28. eng.
22. Sarfstein R, Werner H. Minireview: nuclear insulin and insulin-like growth factor-1 receptors: a novel paradigm in signal transduction. Endocrinology. 2013;154(5):1672-9. PubMed PMID: 23507573. Epub 2013/03/20. eng.
23. Yenush L, White MF. The IRS-signalling system during insulin and cytokine action. Bioessays. 1997;19(6):491-500. PubMed PMID: 9204766. Epub 1997/06/01. eng.
24. Rhee YH, Choi M, Lee HS, Park CH, Kim SM, Yi SH, et al. Insulin concentration is critical in culturing human neural stem cells and neurons. Cell Death Dis. 2013;4, e766. PubMed PMID: 23928705. Pubmed Central PMCID: PMC3763456. Epub 2013/08/10. eng.
25. Oberheim NA, Takano T, Han X, He W, Lin JH, Wang F, et al. Uniquely hominid features of adult human astrocytes. J Neurosci. 2009;29(10):3276-87. PubMed PMID: 19279265. Pubmed Central PMCID: PMC2819812. Epub 2009/03/13. eng.
26. Flynn G, Maru S, Loughlin J, Romero IA, Male D. Regulation of chemokine receptor expression in human microglia and astrocytes. J Neuroimmunol. 2003;136(1-2):84-93. PubMed PMID: 12620646. Epub 2003/03/07. eng.
27. Alessi DR, Andjelkovic M, Caudwell B, Cron P, Morrice N, Cohen P, et al. Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J. 1996;15(23):6541-51. PubMed PMID: 8978681. Pubmed Central PMCID: PMC452479. Epub 1996/12/02. eng.
28. Hemmings BA, Restuccia DF. PI3K-PKB/Akt pathway. Cold Spring Harb Perspect Biol. 2012;4(9):a011189. PubMed PMID: 22952397. Pubmed Central PMCID: PMC3428770. Epub 2012/09/07. eng.
29. Copps KD, White MF. Regulation of insulin sensitivity by serine/threonine phosphorylation of insulin receptor substrate proteins IRS1 and IRS2. Diabetologia. 2012;55(10):2565-82. PubMed PMID: 22869320. Pubmed Central PMCID: PMC4011499. Epub 2012/08/08. eng.
30. Williams S, Roux S, Koekemoer T, van de Venter M, Dealtry G. Sutherlandia frutescens prevents changes in diabetes-related gene expression in a fructose-induced insulin resistant cell model. J Ethnopharmacol. 2013;146(2):482-9. PubMed PMID: 23376105. Epub 2013/02/05. eng.
31. Lowenstein EJ, Daly RJ, Batzer AG, Li W, Margolis B, Lammers R, et al. The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling. Cell. 1992;70(3):431-42. PubMed PMID: 1322798. Epub 1992/08/07. eng.
32. Li N, Batzer A, Daly R, Yajnik V, Skolnik E, Chardin P, et al. Guanine-nucleotide-releasing factor hSos1 binds to Grb2 and links receptor tyrosine kinases to Ras signalling. Nature. 1993;363(6424):85-8. PubMed PMID: 8479541. Epub 1993/05/06. eng.
33. de la Monte SM. Brain insulin resistance and deficiency as therapeutic targets in Alzheimer's disease. Curr Alzheimer Res. 2012;9(1):35-66. PubMed PMID: 22329651. Pubmed Central PMCID: PMC3349985. Epub 2012/02/15. eng.
34. Talbot K, Wang HY, Kazi H, Han LY, Bakshi KP, Stucky A, et al. Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. J Clin Invest. 2012;122(4):1316-38. PubMed PMID: 22476197. Pubmed Central PMCID: PMC3314463. Epub 2012/04/06. eng.
35. De Felice FG, Vieira MN, Bomfim TR, Decker H, Velasco PT, Lambert MP, et al. Protection of synapses against Alzheimer's-linked toxins: insulin signaling prevents the pathogenic binding of Abeta oligomers. Proc Natl Acad Sci U S A. 2009;106(6):1971-6. PubMed PMID: 19188609. Pubmed Central PMCID: PMC2634809. Epub 2009/02/04. eng.
36. Liu Y, Liu F, Grundke-Iqbal I, Iqbal K, Gong CX. Deficient brain insulin signalling pathway in Alzheimer's disease and diabetes. J Pathol. 2011;225(1):54-62. PubMed PMID: 21598254. Epub 2011/05/21. eng.
37. Duarte AI, Moreira PI, Oliveira CR. Insulin in central nervous system: more than just a peripheral hormone. J Aging Res. 2012;2012:384017. Pubmed Central PMCID: PMC3303591. Epub 2012/04/14. eng.
38. Garcia-Segura LM, Rodriguez JR, Torres-Aleman I. Localization of the insulin-like growth factor I receptor in the cerebellum and hypothalamus of adult rats: an electron microscopic study. J Neurocytol. 1997;26(7):479-90. English.
39. Schwartz MW, Figlewicz DP, Baskin DG, Woods SC, Porte Jr D. Insulin in the brain: a hormonal regulator of energy balance. Endocr Rev. 1992;13(3):387-414. PubMed PMID: 1425482. Epub 1992/08/11. eng.
40. Heidenreich KA, Zahniser NR, Berhanu P, Brandenburg D, Olefsky JM. Structural differences between insulin receptors in the brain and peripheral target tissues. J Biol Chem. 1983;258(14):8527-30. PubMed PMID: 6345543. Epub 1983/07/25. eng.
41. Wozniak M, Rydzewski B, Baker SP, Raizada MK. The cellular and physiological actions of insulin in the central nervous system. Neurochem Int. 1993;22(1):1-10. PubMed PMID: 8443563. Epub 1993/01/01. eng.
42. Clarke DW, Boyd Jr FT, Kappy MS, Raizada MK. Insulin binds to specific receptors and stimulates 2-deoxy-D-glucose uptake in cultured glial cells from rat brain. J Biol Chem. 1984;259(19):11672-5. PubMed PMID: 6384211. Epub 1984/10/10. eng.
43. Heni M, Hennige AM, Peter A, Siegel-Axel D, Ordelheide AM, Krebs N, et al. Insulin promotes glycogen storage and cell proliferation in primary human astrocytes. PLoS One. 2011;6(6):e21594. PubMed PMID: 21738722. Pubmed Central PMCID: PMC3124526. Epub 2011/07/09. eng.
44. Frasca F, Pandini G, Scalia P, Sciacca L, Mineo R, Costantino A, et al. Insulin receptor isoform A, a newly recognized, high-affinity insulin-like growth factor II receptor in fetal and cancer cells. Mol Cell Biol. 1999;19(5):3278-88. PubMed PMID: 10207053. Pubmed Central PMCID: PMC84122. Epub 1999/04/17. eng.
45. Seifert G, Steinhauser C. Neuron-astrocyte signaling and epilepsy. Exp Neurol. 2013;244:4-10. PubMed PMID: 21925173. Epub 2011/09/20. eng.
46. Wagner B, Natarajan A, Grunaug S, Kroismayr R, Wagner EF, Sibilia M. Neuronal survival depends on EGFR signaling in cortical but not midbrain astrocytes. EMBO J. 2006;25(4):752-62. PubMed PMID: 16467848. Pubmed Central PMCID: PMC1383568. Epub 2006/02/10. eng.
47. Reiss K, Del Valle L, Lassak A, Trojanek J. Nuclear IRS-1 and cancer. J Cell Physiol. 2012;227(8):2992-3000. PubMed PMID: 22454254. Pubmed Central PMCID: PMC3615708. Epub 2012/03/29. eng.
48. Ince PG, Highley JR, Kirby J, Wharton SB, Takahashi H, Strong MJ, et al. Molecular pathology and genetic advances in amyotrophic lateral sclerosis: an emerging molecular pathway and the significance of glial pathology. Acta Neuropathol. 2011;122(6):657-71. PubMed PMID: 22105541. Epub 2011/11/23. eng.
49. Reger MA, Watson GS, Frey 2nd WH, Baker LD, Cholerton B, Keeling ML, et al. Effects of intranasal insulin on cognition in memory-impaired older adults: modulation by APOE genotype. Neurobiol Aging. 2006;27(3):451-8. PubMed PMID: 15964100. Epub 2005/06/21. eng.
50. Reger MA, Watson GS, Green PS, Wilkinson CW, Baker LD, Cholerton B, et al. Intranasal insulin improves cognition and modulates beta-amyloid in early AD. Neurology. 2008;70(6):440-8. PubMed PMID: 17942819. Epub 2007/10/19. eng.
51. Dhamoon MS, Noble JM, Craft S. Intranasal insulin improves cognition and modulates beta-amyloid in early AD. Neurology. 2009;72(3):292-3. author reply 3-4. PubMed PMID: 19153380. Epub 2009/01/21. eng.
52. Hailey J, Maxwell E, Koukouras K, Bishop WR, Pachter JA, Wang Y. Neutralizing anti-insulin-like growth factor receptor 1 antibodies inhibit receptor function and induce receptor degradation in tumor cells. Mol Cancer Ther. 2002;1(14):1349-53. PubMed PMID: 12516969. Epub 2003/01/09. eng.
53. Soos MA, Whittaker J, Lammers R, Ullrich A, Siddle K. Receptors for insulin and insulin-like growth factor-I can form hybrid dimers. Characterisation of hybrid receptors in transfected cells. Biochem J. 1990;270(2):383-90. PubMed PMID: 1698059. Pubmed Central PMCID: PMC1131733. Epub 1990/09/01. eng.
54. Singh P, Alex JM, Bast F. Insulin receptor (IR) and insulin-like growth factor receptor 1 (IGF-1R) signaling systems: novel treatment strategies for cancer. Med Oncol (Northwood, London, England). 2014;31(1):805. PubMed PMID: 24338270. Epub 2013/12/18. eng.
55. Buck E, Gokhale PC, Koujak S, Brown E, Eyzaguirre A, Tao N, et al. Compensatory insulin receptor (IR) activation on inhibition of insulin-like growth factor-1 receptor (IGF-1R): rationale for cotargeting IGF-1R and IR in cancer. Mol Cancer Ther. 2010;9(10):2652-64. PubMed PMID: 20924128. Epub 2010/10/07. eng.
56. Dalle Pezze P, Nelson G, Otten EG, Korolchuk VI, Kirkwood TB, von Zglinicki T, et al. Dynamic modelling of pathways to cellular senescence reveals strategies for targeted interventions. PLoS Comput Biol. 2014;10(8):e1003728. PubMed PMID: 25166345. Pubmed Central PMCID: PMC4159174. Epub 2014/08/29. eng.
57. Genis L, Davila D, Fernandez S, Pozo-Rodrigalvarez A, Martinez-Murillo R, Torres-Aleman I. Astrocytes require insulin-like growth factor I to protect neurons against oxidative injury. F1000Res. 2014;3:28. PubMed PMID: 24715976. Pubmed Central PMCID: PMC3954172. Epub 2014/04/10. eng.
58. Zlokovic BV. Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders. Nat Rev Neurosci. 2011;12(12):723-38. PubMed PMID: 22048062. Epub 2011/11/04. eng.
59. Scholz D, Poltl D, Genewsky A, Weng M, Waldmann T, Schildknecht S, et al. Rapid, complete and large-scale generation of post-mitotic neurons from the human LUHMES cell line. J Neurochem. 2011;119(5):957-71. PubMed PMID: 21434924. Epub 2011/03/26. eng.